Literature DB >> 26764596

Antigen Export Reduces Antigen Presentation and Limits T Cell Control of M. tuberculosis.

Smita Srivastava1, Patricia S Grace2, Joel D Ernst3.   

Abstract

Persistence of Mycobacterium tuberculosis results from bacterial strategies that manipulate host adaptive immune responses. Infected dendritic cells (DCs) transport M. tuberculosis to local lymph nodes but activate CD4 T cells poorly, suggesting bacterial manipulation of antigen presentation. However, M. tuberculosis antigens are also exported from infected DCs and taken up and presented by uninfected DCs, possibly overcoming this blockade of antigen presentation by infected cells. Here we show that the first stage of this antigen transfer, antigen export, benefits M. tuberculosis by diverting bacterial proteins from the antigen presentation pathway. Kinesin-2 is required for antigen export and depletion of this microtubule-based motor increases activation of antigen-specific CD4 T cells by infected cells and improves control of intracellular infection. Thus, although antigen transfer enables presentation by bystander cells, it does not compensate for reduced antigen presentation by infected cells and represents a bacterial strategy for CD4 T cell evasion.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26764596      PMCID: PMC4715867          DOI: 10.1016/j.chom.2015.12.003

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  42 in total

Review 1.  Kinesin superfamily motor proteins and intracellular transport.

Authors:  Nobutaka Hirokawa; Yasuko Noda; Yosuke Tanaka; Shinsuke Niwa
Journal:  Nat Rev Mol Cell Biol       Date:  2009-10       Impact factor: 94.444

2.  Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages.

Authors:  Emmanuel L Gautier; Tal Shay; Jennifer Miller; Melanie Greter; Claudia Jakubzick; Stoyan Ivanov; Julie Helft; Andrew Chow; Kutlu G Elpek; Simon Gordonov; Amin R Mazloom; Avi Ma'ayan; Wei-Jen Chua; Ted H Hansen; Shannon J Turley; Miriam Merad; Gwendalyn J Randolph
Journal:  Nat Immunol       Date:  2012-09-30       Impact factor: 25.606

Review 3.  Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review.

Authors:  Stefan H E Kaufmann; Christoph Lange; Martin Rao; Kithiganahalli N Balaji; Michael Lotze; Marco Schito; Alimuddin I Zumla; Markus Maeurer
Journal:  Lancet Respir Med       Date:  2014-03-24       Impact factor: 30.700

4.  Cutting edge: Direct recognition of infected cells by CD4 T cells is required for control of intracellular Mycobacterium tuberculosis in vivo.

Authors:  Smita Srivastava; Joel D Ernst
Journal:  J Immunol       Date:  2013-07-01       Impact factor: 5.422

Review 5.  The immunological life cycle of tuberculosis.

Authors:  Joel D Ernst
Journal:  Nat Rev Immunol       Date:  2012-07-13       Impact factor: 53.106

6.  Genetic regulation of vesiculogenesis and immunomodulation in Mycobacterium tuberculosis.

Authors:  Poonam Rath; Chengdong Huang; Tao Wang; Tianzhi Wang; Huilin Li; Rafael Prados-Rosales; Olivier Elemento; Arturo Casadevall; Carl F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

7.  Critical role for the kinesin KIF3A in the HIV life cycle in primary human macrophages.

Authors:  Raphaël Gaudin; Bruna Cunha de Alencar; Mabel Jouve; Stefano Bèrre; Emmanuel Le Bouder; Michael Schindler; Aditi Varthaman; François-Xavier Gobert; Philippe Benaroch
Journal:  J Cell Biol       Date:  2012-10-22       Impact factor: 10.539

8.  Deciphering the transcriptional network of the dendritic cell lineage.

Authors:  Jennifer C Miller; Brian D Brown; Tal Shay; Emmanuel L Gautier; Vladimir Jojic; Ariella Cohain; Gaurav Pandey; Marylene Leboeuf; Kutlu G Elpek; Julie Helft; Daigo Hashimoto; Andrew Chow; Jeremy Price; Melanie Greter; Milena Bogunovic; Angelique Bellemare-Pelletier; Paul S Frenette; Gwendalyn J Randolph; Shannon J Turley; Miriam Merad
Journal:  Nat Immunol       Date:  2012-07-15       Impact factor: 25.606

9.  Sequence diversity in the pe_pgrs genes of Mycobacterium tuberculosis is independent of human T cell recognition.

Authors:  Richard Copin; Mireia Coscollá; Salome N Seiffert; Graham Bothamley; Jayne Sutherland; Georgetta Mbayo; Sebastien Gagneux; Joel D Ernst
Journal:  mBio       Date:  2014-01-14       Impact factor: 7.867

10.  Essential yet limited role for CCR2⁺ inflammatory monocytes during Mycobacterium tuberculosis-specific T cell priming.

Authors:  Miriam Samstein; Heidi A Schreiber; Ingrid M Leiner; Boze Susac; Michael S Glickman; Eric G Pamer
Journal:  Elife       Date:  2013-11-12       Impact factor: 8.140

View more
  33 in total

Review 1.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

2.  "The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" - Meeting report.

Authors:  Cesar Boggiano; Katrin Eichelberg; Lakshmi Ramachandra; Jaqueline Shea; Lalita Ramakrishnan; Samuel Behar; Joel D Ernst; Steven A Porcelli; Markus Maeurer; Hardy Kornfeld
Journal:  Vaccine       Date:  2017-05-02       Impact factor: 3.641

Review 3.  Immunometabolism at the interface between macrophages and pathogens.

Authors:  David G Russell; Lu Huang; Brian C VanderVen
Journal:  Nat Rev Immunol       Date:  2019-05       Impact factor: 53.106

Review 4.  Immunology of Mycobacterium tuberculosis Infections.

Authors:  Jonathan Kevin Sia; Jyothi Rengarajan
Journal:  Microbiol Spectr       Date:  2019-07

Review 5.  Targeting innate immunity for tuberculosis vaccination.

Authors:  Shabaana A Khader; Maziar Divangahi; Willem Hanekom; Philip C Hill; Markus Maeurer; Karen W Makar; Katrin D Mayer-Barber; Musa M Mhlanga; Elisa Nemes; Larry S Schlesinger; Reinout van Crevel; Raman (Krishna) Vankayalapati; Ramnik J Xavier; Mihai G Netea
Journal:  J Clin Invest       Date:  2019-09-03       Impact factor: 14.808

6.  Limited Antimycobacterial Efficacy of Epitope Peptide Administration Despite Enhanced Antigen-Specific CD4 T-Cell Activation.

Authors:  Joel D Ernst; Amber Cornelius; Ludovic Desvignes; Jacqueline Tavs; Brian A Norris
Journal:  J Infect Dis       Date:  2018-10-05       Impact factor: 5.226

7.  Cutting Edge: Bacillus Calmette-Guérin-Induced T Cells Shape Mycobacterium tuberculosis Infection before Reducing the Bacterial Burden.

Authors:  Jared L Delahaye; Benjamin H Gern; Sara B Cohen; Courtney R Plumlee; Shahin Shafiani; Michael Y Gerner; Kevin B Urdahl
Journal:  J Immunol       Date:  2019-07-15       Impact factor: 5.422

Review 8.  Fighting Persistence: How Chronic Infections with Mycobacterium tuberculosis Evade T Cell-Mediated Clearance and New Strategies To Defeat Them.

Authors:  Laurisa Ankley; Sean Thomas; Andrew J Olive
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 9.  Antigenic Variation and Immune Escape in the MTBC.

Authors:  Joel D Ernst
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 10.  Mechanisms of M. tuberculosis Immune Evasion as Challenges to TB Vaccine Design.

Authors:  Joel D Ernst
Journal:  Cell Host Microbe       Date:  2018-07-11       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.